These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 3632251

  • 1. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
    Wolkowitz OM, Doran AR, Breier A, Roy A, Jimerson DC, Sutton ME, Golden RN, Paul SM, Pickar D.
    Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
    [Abstract] [Full Text] [Related]

  • 2. Dexamethasone increases plasma HVA but not MHPG in normal humans.
    Wolkowitz OM, Sutton ME, Doran AR, Labarca R, Roy A, Thomas JW, Pickar D, Paul SM.
    Psychiatry Res; 1985 Oct; 16(2):101-9. PubMed ID: 3865250
    [Abstract] [Full Text] [Related]

  • 3. Specificity of plasma HVA response to dexamethasone in psychotic depression.
    Wolkowitz OM, Doran A, Breier A, Roy A, Pickar D.
    Psychiatry Res; 1989 Aug; 29(2):177-86. PubMed ID: 2798596
    [Abstract] [Full Text] [Related]

  • 4. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
    Roy A, Jimerson DC, Pickar D.
    Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
    [Abstract] [Full Text] [Related]

  • 5. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls.
    Azorin JM, Raucoules D, Valli M, Levy C, Lancon C, Luccioni JM, Tissot R.
    Neuropsychobiology; 1990 Jul; 23(1):18-24. PubMed ID: 2280827
    [Abstract] [Full Text] [Related]

  • 6. Increased plasma MHPG in dexamethasone-resistant depressed patients.
    Jimerson DC, Insel TR, Reus VI, Kopin IJ.
    Arch Gen Psychiatry; 1983 Feb; 40(2):173-6. PubMed ID: 6824413
    [Abstract] [Full Text] [Related]

  • 7. Noradrenergic function and the dexamethasone suppression test in depression.
    Morinobu S, Satoh H, Endoh M, Totsuka S.
    Jpn J Psychiatry Neurol; 1987 Dec; 41(4):669-76. PubMed ID: 3453415
    [Abstract] [Full Text] [Related]

  • 8. The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions.
    Sack DA, James SP, Doran AR, Sherer MA, Linnoila M, Wehr TA.
    Arch Gen Psychiatry; 1988 Feb; 45(2):162-6. PubMed ID: 3337614
    [Abstract] [Full Text] [Related]

  • 9. Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression?
    Halbreich U, Sharpless N, Asnis GM, Endicott J, Goldstein S, Vital-Herne J, Eisenberg J, Zander K, Kang BJ, Shindledecker R.
    Arch Gen Psychiatry; 1987 Sep; 44(9):804-12. PubMed ID: 3632254
    [Abstract] [Full Text] [Related]

  • 10. Characteristics of patients with the highest plasma catecholamine metabolite levels.
    Bowers MB, Swigar ME, Hoffman FJ, Goicoechea N.
    Am J Psychiatry; 1988 Feb; 145(2):246-8. PubMed ID: 3422545
    [Abstract] [Full Text] [Related]

  • 11. Plasma catecholamine metabolites in subtypes of major depression.
    Mazure CM, Bowers MB, Hoffman F, Miller KB, Nelson JC.
    Biol Psychiatry; 1987 Dec; 22(12):1469-72. PubMed ID: 3676373
    [No Abstract] [Full Text] [Related]

  • 12. Elevated plasma homovanillic acid in depressed females with melancholia and psychosis.
    Devanand DP, Bowers MB, Hoffman FJ, Nelson JC.
    Psychiatry Res; 1985 May; 15(1):1-4. PubMed ID: 3859880
    [Abstract] [Full Text] [Related]

  • 13. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D, Levy C, Azorin JM, Bruno M, Valli M.
    Encephale; 1992 May; 18(6):611-6. PubMed ID: 1285270
    [Abstract] [Full Text] [Related]

  • 14. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
    Mazure CM, Nelson JC, Jatlow PI, Bowers MB.
    Biol Psychiatry; 1991 Sep 01; 30(5):475-82. PubMed ID: 1932395
    [Abstract] [Full Text] [Related]

  • 15. Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in- and outpatients.
    Syvälahti E.
    Acta Psychiatr Scand; 1985 Feb 01; 71(2):105-10. PubMed ID: 3976406
    [Abstract] [Full Text] [Related]

  • 16. Apparent phase advance in diurnal MHPG rhythm in depression.
    Gwirtsman HE, Halaris AE, Wolf AW, DeMet E, Piletz JE, Marler M.
    Am J Psychiatry; 1989 Nov 01; 146(11):1427-33. PubMed ID: 2817113
    [Abstract] [Full Text] [Related]

  • 17. Neuroendocrine and neurochemical measurements in depression.
    Davis KL, Hollister LE, Mathé AA, Davis BM, Rothpearl AB, Faull KF, Hsieh JY, Barchas JD, Berger PA.
    Am J Psychiatry; 1981 Dec 01; 138(12):1555-62. PubMed ID: 6171169
    [Abstract] [Full Text] [Related]

  • 18. Diurnal changes in dopamine-beta-hydroxylase, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in serum of man.
    Markianos E, Backman H.
    J Neural Transm; 1976 Dec 01; 39(1-2):79-93. PubMed ID: 988114
    [Abstract] [Full Text] [Related]

  • 19. The heterogeneity of 3-methoxy-4-hydroxyphenylglycol levels among depressed patients.
    Karege F, Bovier P, Gaillard JM, Tissot R.
    Acta Psychiatr Scand; 1989 Nov 01; 80(5):499-504. PubMed ID: 2596350
    [Abstract] [Full Text] [Related]

  • 20. Acute and subacute effects of ECT on plasma HVA, MHPG, and prolactin.
    Devanand DP, Bowers MB, Hoffman FJ, Sackeim HA.
    Biol Psychiatry; 1989 Aug 01; 26(4):408-12. PubMed ID: 2765601
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.